IPCA Laboratories Limited
IPCA Laboratories Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: IPCALAB and BSE: 524494 (ISIN INE571A01038).
It has a market capitalisation of ₹46,034 crore, a last close of ₹1,815 on 2026-10-19, a one-year return of 41.1%.
Valuation: a price-to-earnings ratio of 35.15x, a price-to-book ratio of 5.71x, a dividend yield of 0.3%.
Profitability: return on equity of 15.2%, return on capital employed of 17.0%, an operating margin of 22.0%.
Growth: sales growth of 15.6% a year over three years, net profit growth of 34.3% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.09x, promoter holding of 44.7%.
| Metric | Value |
|---|---|
| Market capitalisation | 46,034 |
| Last close | ₹1,815 |
| P/E (TTM) | 35.15x |
| P/B | 5.71x |
| Dividend yield | 0.3% |
| ROE (FY) | 15.2% |
| ROCE (FY) | 17.0% |
| Operating margin (TTM) | 22.0% |
| Sales growth, 3-year CAGR | 15.6% |
| Profit growth, 3-year CAGR | 34.3% |
| Debt / equity | 0.09x |
| Promoter holding | 44.7% |
| 1-year return | 41.1% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means